Sofosbuvir/velpatasvir: A promising combination
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Viruses | Free Full-Text | Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
Antivirals for Hepatitis C | Concise Medical Knowledge
Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Velpatasvir - an overview | ScienceDirect Topics
Evolution of efficacious pangenotypic hepatitis C virus therapies - Ashraf - 2019 - Medicinal Research Reviews - Wiley Online Library
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Plant Uptake and Metabolism of 2,4-Dibromophenol in Carrot: In Vitro Enzymatic Direct Conjugation | Journal of Agricultural and Food Chemistry
PathWhiz
Structure-activity relationships of fluorene compounds inhibiting HCV variants - ScienceDirect
Advances in Treatment of Hepatitis C | IntechOpen
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Sofosbuvir - Wikipedia
Sofosbuvir/Velpatasvir (Epclusa®) Drug Interactions A Quick Guide for Clinicians – February 2019
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
Epclusa, INN-sofosbuvir/velpatasvir
Sofosbuvir - Wikipedia
Cells | Free Full-Text | Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Frontiers | Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
